150 related articles for article (PubMed ID: 29095895)
1. Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats.
Chen YC; Ho CC; Yi CH; Liu XZ; Cheng TT; Lam CF
PLoS One; 2017; 12(11):e0187434. PubMed ID: 29095895
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
[TBL] [Abstract][Full Text] [Related]
3. Experimental healing of preexisting gastric ulcers induced by hormones controlling food intake ghrelin, orexin-A and nesfatin-1 is impaired under diabetic conditions. A key to understanding the diabetic gastropathy?
Szlachcic A; Majka J; Strzalka M; Szmyd J; Pajdo R; Ptak-Belowska A; Kwiecien S; Brzozowski T
J Physiol Pharmacol; 2013 Oct; 64(5):625-37. PubMed ID: 24304576
[TBL] [Abstract][Full Text] [Related]
4. Role of activation of 5'-adenosine monophosphate-activated protein kinase in gastric ulcer healing in diabetic rats.
Baraka AM; Deif MM
Pharmacology; 2011; 88(5-6):275-83. PubMed ID: 22068032
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
6. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
[TBL] [Abstract][Full Text] [Related]
8. Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats.
Baraka AM; Guemei A; Gawad HA
Biochem Pharmacol; 2010 Jun; 79(11):1634-9. PubMed ID: 20144589
[TBL] [Abstract][Full Text] [Related]
9. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats.
Konturek PC; Brzozowski T; Burnat G; Szlachcic A; Koziel J; Kwiecien S; Konturek SJ; Harsch IA
J Physiol Pharmacol; 2010 Aug; 61(4):429-36. PubMed ID: 20814070
[TBL] [Abstract][Full Text] [Related]
10. The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression.
Zeng Y; Yang K; Wang F; Zhou L; Hu Y; Tang M; Zhang S; Jin S; Zhang J; Wang J; Li W; Lu L; Xu GT
Exp Eye Res; 2016 Oct; 151():203-11. PubMed ID: 27212443
[TBL] [Abstract][Full Text] [Related]
11. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
12. Impaired gastric ulcer healing in diabetic mice: role of methylglyoxal.
Naito Y; Takagi T; Oya-Ito T; Okada H; Suzuki T; Hirata I; Hirai M; Uchiyama K; Handa O; Uchida K; Yoshikawa T
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():123-30. PubMed ID: 20388955
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice.
Gezginci-Oktayoglu S; Sacan O; Yanardag R; Karatug A; Bolkent S
Peptides; 2011 Feb; 32(2):223-31. PubMed ID: 21055431
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 improves the oral glucose tolerance in diabetic rats: pancreas regeneration, better function of pancreatic islets, or impaired glucose uptake?
Strauss A; Moskalenko V; Chodnevskaja I; Timm S; Thiede A; Otto C; Ulrichs K
Transplant Proc; 2008 Mar; 40(2):533-5. PubMed ID: 18374122
[TBL] [Abstract][Full Text] [Related]
17. Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats.
Barakat GM; Moustafa ME; Bikhazi AB
Biochem Genet; 2012 Dec; 50(11-12):922-35. PubMed ID: 22983684
[TBL] [Abstract][Full Text] [Related]
18. [Melatonin as a therapeutic factor in gastric ulcer healing under experimental diabetes].
Magierowski M; Jasnos K; Brzozowska I; Drozdowicz D; Sliwowski Z; Nawrot E; Szczyrk U; Kwiecień S
Przegl Lek; 2013; 70(11):942-6. PubMed ID: 24697035
[TBL] [Abstract][Full Text] [Related]
19. Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Neri G; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Oct; 12(4):593-6. PubMed ID: 12964040
[TBL] [Abstract][Full Text] [Related]
20. Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
McLaughlin PJ; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2013 Jul; 238(7):733-43. PubMed ID: 23788174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
